Published in

Wiley, Dermatologic Therapy, 6(33), 2020

DOI: 10.1111/dth.14258

Links

Tools

Export citation

Search in Google Scholar

Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO